Financial Results Nine month period 2019 - Video

Javier López-Belmonte, Vicepresident and CFO of Laboratorios Farmacéuticos ROVI presents the financial results for the first nine months of 2019.


No votes yet
 
Related
ROVI recibe la opinión positiva del CHMP para Okedi® como tratamiento de la esquizofrenia
Laboratorios Farmacéuticos Rovi, a pan-European pharmaceutical company specializing and engaging in the research, development, contract...
4 min
17/12/2021
2021 Capital Markets Day presentation
TO THE SPANISH NATIONAL SECURITIES MARKET COMMISSION (COMISIÓN NACIONAL DEL MERCADO DE VALORES) Madrid, 16 November 2021 In...
1 min
16/11/2021
First Nine Months 2021 Results Press Release
REVENUES Laboratorios Farmacéuticos Rovi, S.A. (BME: ROVI), a pan-European pharmaceutical company specialized and dedicated to the...
5 min
03/11/2021